Waxsen Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 14.15 Cr
- Satisfied Charges ₹ 4.80 M
- Revenue Growth -50.02%
- Profit Growth -42.49%
- Ebitda 3.38%
- Net Worth 6.36%
- Total Assets -10.15%
About Waxsen Lifescience
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24297MH2009PTC197046
- Company No.
197046
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Nov 2009
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Waxsen Lifescience?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shilpi Mandhana  | Director | 09-Aug-2010 | Current |
| Subhash Agarwal | Additional Director | 10-Feb-2022 | Current |
| Suresh Mandhana | Director | 17-Feb-2014 | Current |
Financial Performance of Waxsen Lifescience.
Waxsen Lifescience Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 50.02% decrease. The company also saw a substantial fall in profitability, with a 42.49% decrease in profit. The company's net worth moved up by a moderate rise of 6.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Waxsen Lifescience?
In 2019, Waxsen Lifescience had a promoter holding of 55.00% and a public holding of 45.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
A-Mark Pharma Private LimitedShilpi Mandhana and Suresh Mandhana are mutual person
- Chemserves Pharma Private Limited
Suresh Mandhana is a mutual person
- Relichem Pharma Private Limited
Suresh Mandhana is a mutual person
Charges (Loans)
₹141.50 M
₹4.80 M
Charges Breakdown by Lending Institutions
- Others : 14.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2014 | Others | ₹14.15 Cr | Open |
| 24 Jul 2012 | Bank Of Baroda | ₹4.80 M | Satisfied |
How Many Employees Work at Waxsen Lifescience?
Waxsen Lifescience has a workforce of 26 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Waxsen Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Waxsen Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
